Chronic Obstructive Pulmonary Disorder (COPD) at ATS
The most recent updated guidelines from the Global Strategy for the Diagnosis, Management, and Prevention (GOLD), issued in December 2011, recommend that clinicians incorporate symptom assessment tools into their decision making regarding treatment. Specifically, they advise using the COPD Assessment Test (CAT) every 2 to 3 months to identify “trends and changes,” rather than relying only on annual spirometry. The goal is to focus on improving quality of life, not just symptoms; the two do not always correlate.
The higher the score on the 8-item CAT test, the worse the patient’s quality of life. Patients can even take the test online (http://www.catestonline.org/english/indexEN.htm) and bring it with them for their appointments. Tracking the score over time can provide insight into how quickly the disease is progressing. A change of 2 points is considered clinically relevant. Scores below 10 are considered low; 10-20, medium; 21-30, high; and greater than 30, very high, with specific management options recommended in each category.1
Several presentations at ATS will document how clearly the CAT test indicates function and quality of life among COPD patients, some of whom don’t even show symptoms. A number of the abstracts have implications for the way COPD is treated.
CAT testing in smokers. In one study, researchers gave the CAT to 342 heavy smokers, 68% of them currently smokers. None had yet been diagnosed with COPD, although several received the diagnosis during the study. Asymptomatic daily smokers with normal lung function had mean CAT scores of 8.6, while symptomatic smokers with normal lung function had mean CAT scores of 13.0, as did the participants who had GOLD II disease. Those with severe COPD or exacerbation scored an average of 20.9. Take-home message: Even patients with a smoking history who have normal lung function, as well as those with mild-to-moderate COPD, may have significantly impaired quality of life. Consider beginning treatment early and optimizing management.2
CAT and exacerbations. Several studies found links between CAT scores and exacerbations. In one, high CAT scores were associated with exacerbation frequency even in patients with mild airflow limitation. These patients also were less active indoors and experienced more gastrointestinal reflux disease.3 Meanwhile, among 161 patients who completed the CAT during an exacerbation and at least 5 weeks after, the CAT score at the time of the exacerbation correlated significantly with systemic inflammatory markers, providing a reliable indication of exacerbation intensity that could guide treatment. The score was also a good marker to assess improvement in the weeks following exacerbation.4
Finally, a retrospective study of 39 patients with moderate-to-severe COPD found that CAT provided a clear marker for worsening disease and functional capacity. The authors recommended using it to determine “more effective interventions in the natural history of the disease.” 5
Screening for COPD. There is considerable debate as to the appropriateness of COPD screening, particularly in primary care offices where access to spirometry may be limited.6 After all, not every smoker develops COPD. A study that will be presented at ATS, however, found that smoking history, age > 55 years, and presence of exertional breathlessness reliably predicted patients at risk for COPD for whom spirometry is appropriate.7
Dyspnea in COPD. Dyspnea is the classic symptom of COPD, one that clinicians aim to improve with treatment. However, a study to be presented at ATS found that 44% of a cohort of 42,175 COPD patients had clinically significantly dyspnea regardless of their GOLD stage and current treatment. Take-home message: A significant percentage of patients are not being treated aggressively enough to manage their symptoms and improve their quality of life.8
Watch out for fatigue. More than half of COPD patients experience chronic fatigue. Yet there is disagreement on how to assess and manage fatigue in these patients, leading to significant underdiagnosis and undertreatment.9 A study that will be presented at ATS involving 101 patients with stable COPD found that 66% experienced fatigue, mainly those with more reduced lung function, shorter 6-minute walking distances, and greater dyspnea. These patients were also more likely to experience depression and anxiety than those without fatigue.10 Take-home message: Don’t ignore fatigue in your COPD patients. It could be contributing to other comorbidities and affecting quality of life, and it can be improved with proper management. Evidence-based approaches to improving fatigue in patients with COPD include pulmonary rehabilitation and nutritional support.11
1. Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648-54.
2. Toljamo T, et al. Value Of COPD Assessment Test (CAT) In Symptomatic Smokers Without COPD. T. Toljamo, Am J Respir Crit Care Med 185;2012:A1505
3. Miyazaki M, et al. Analysis Of Comorbid Factors Raising CAT Scores In COPD Patients With Mild Airflow Limitation. Am J Respir Crit Care Med;185;2012:A1507
4. Mackay AJ, et al. Utility Of The COPD Assessment Test (CAT) To Evaluate Severity Of COPD Exacerbations. Am J Respir Crit Care Med 185;2012:A1513
5. Gomes T, et al. Measuring The Real Impact To Improve Management Of Disease. Am J Respir Crit Care Med 185;2012:A1508
6. Lin K, Watkins B, Johnson T, Rodriguez JA, Barton MB. Screening for Chronic Obstructive Pulmonary Disease Using Spirometry: Summary of the Evidence for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008.
7. N. Raghavan, et al. Utility Of The COPD Assessment Test (CAT) In Predicting A Diagnosis Of COPD. Am J Respir Crit Care Med 185;2012:A1506
8. Mullerova H, et al. Disease Burden Of Dyspnea In A Primary Care COPD Population. Am J Respir Crit Care Med 185;2012:A1518
9. Wong CJ, et al. Fatigue in patients with COPD participating in a pulmonary rehabilitation program. Int J Chronic Obstruct Dis. 2010;5:319-326.
10. Kentson MU, et al. Situational, Physiological And Psychological Factors Associated With COPD-Related Fatigue And Functional Limitations Due To Fatigue. Am J Respir Crit Care Med 185;2012:A1519
11. Payne C, Wiffen PJ, Martin S. Interventions for fatigue and weight loss in adults with advanced progressive illness. Cochrane Database Syst Rev. 2012 Jan 18;1:CD008427.
12. Young T, Palta M, Dempsey J, et al. Burden of sleep apnea: rationale, design, and major findings of the Wisconsin Sleep Cohort study. WMJ. 2009;108(5):246
13. Epstein LJ, Kristo D, Strollo PJ, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5(3):263.
14. Sliwinksi P, et al. Relationship Between Arterial Hypertension And Impaired Glucose Tolerance (IGT) In Obstructive Sleep Apnoea (OSA) Patients. Am J Respir Crit Care Med. 185;2012:A2161
15. Gu C, et al. Impaired Glucose Tolerance And Pancreatic Beta Cell Function In Patients With Obstructive Sleep Apnea. Am J Respir Crit Care Med. 185;2012:A2165.
16. Zhao Q, et al. Correlation Analysis Of Obstructive Sleep Apnea And Insulin Resistance. Am J Respir Crit Care Med. 185;2012:A2163.
17. Iftikhar I. Meta-Analysis: Continuous Positive Airway Pressure Therapy Improves Insulin Resistance In Patients With Obstructive Sleep Apnea. Am J Respir Crit Care Med. 185;2012:A2162
18. Sharma SK, Agrawal S, Damodaran D, et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med. 2011 Dec 15;365(24):2277-86
19. Chai-Coetzer CL, et al. Randomised Controlled Trial To Evaluate A Simplified Model Of Care For Obstructive Sleep Apnea In Primary Care. Am J Respir Crit Care Med. 185;2012:A3853
20. Black-Shinn JL, et al. Overlap Syndrome Is Associated With Cardiovascular Disease. Am J Respir Crit Care Med. 185;2012:A2169
21. Tarini BA, et al. Systematic Review of the Relationship Between Early Introduction of Solid Foods to Infants and the Development of Allergic Disease. Arch Pediatr Adolesc Med. 2006;160:502-507
22. Zutavern A, et al. Timing of solid food introduction in relation to eczema, asthma, allergic rhinitis, and food and inhalant sensitization at the age of 6 years: results from the prospective birth cohort study LISA. Pediatrics. 2008 Jan;121(1):e44-52.
23. Concepcion E, et al. Exercise Induced Bronchospasm In Asthmatic And Non-Asthmatic Obese Children. Am J Respir Crit Care Med. 185;2012:A1767.
24. Jolly GP, et al. Evaluation Of Inhaler Usage Technique And Response To Educational Training In A Tertiary Health Care Centre. Am J Respir Crit Care Med. 185;2012:A3328
25. Lo T, et al. Modern Inhalers: to What Degree Are We Capable of Remembering How to Use Them? Am J Respir Crit Care Med. 185;2012:A3331